Success Metrics

Clinical Success Rate

80.0%

Based on 4 completed trials

Completion Rate

80%(4/5)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

1(20%)

Phase Distribution

Ph not_applicable

80%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

N/ANon-phased studies

4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Terminated(1)

Detailed Status

Completed4

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

80.0%

Most Advanced

N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed480%

terminated120%

Recent Activity

0 active trials

Showing 5 of 5

completednot_applicable

Nitric Oxide Flux and Ureagenesis in Argininosuccinate Synthetase Deficiency (ASSD)(Citrullinemia I)

NCT01610089

Clinical Trials (5)

Showing 5 of 5 trials

NCT02733120Not Applicable

Metabolic Processes in Adults and Adolescents With Autism Spectrum Disorder

Completed

NCT02757638Not Applicable

Omics Profiling of Weight Loss With Bariatric Surgery

Completed

NCT06801964Not Applicable

AECOPD and Nutritional Supplementation in COPD

Completed

NCT02113215

Very Low Density Lipoprotein Turnover in Young and Elderly Individuals

Terminated

NCT01610089Not Applicable

Nitric Oxide Flux and Ureagenesis in Argininosuccinate Synthetase Deficiency (ASSD)(Citrullinemia I)

Completed

All 5 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 5